New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
10:04 EDTSALE, QLTI, PIKE, OCN, LRE, LRN, ILIAF, ESI, HCOM, FIVN, FRPOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: FairPoint (FRP) downgraded to Hold from Buy at Drexel Hamilton... Five9 (FIVN) downgraded at Pacific Crest... Hawaiian Telcom (HCOM) downgraded to Equal Weight from Overweight at Stephens... ITT Educational (ESI) downgraded to Underperform from Neutral at BofA/Merrill... Iliad (ILIAF) downgraded to Neutral from Buy at UBS... K12 (LRN) downgraded to Hold from Buy at Stifel... LRR Energy (LRE) downgraded to Market Perform from Outperform at Wells Fargo... Ocwen Financial (OCN) downgraded at Oppenheimer... Pike Electric (PIKE) downgraded to Hold from Buy at BB&T... QLT Inc. (QLTI) downgraded to Neutral from Buy at Roth Capital... RetailMeNot (SALE) downgraded at RBC Capital.
News For FRP;FIVN;HCOM;ESI;ILIAF;LRN;LRE;OCN;PIKE;QLTI;SALE From The Last 14 Days
Check below for free stories on FRP;FIVN;HCOM;ESI;ILIAF;LRN;LRE;OCN;PIKE;QLTI;SALE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 14, 2014
13:51 EDTQLTIAuxilium looks like 'overpriced tax shelter', Barron's says
Auxilium's (AUXL) acquisition of QLT (QLTI) for tax inversion purposes followed a collapse in Testim sales and the company "seems like an overpriced tax shelter," Barron's argues in a follow up article. Reference Link
September 12, 2014
07:03 EDTQLTIQLT announces positive final results from Phase 1b retreatment with QLT091001
QLT Inc. announced positive final results from its international, multi-center, Phase 1b clinical trial of repeated treatments of oral QLT091001 in subjects with Leber Congenital Amaurosis or Retinitis Pigmentosa due to inherited genetic mutations in retinal pigment epithelium or lecithin:retinol acyltransferase. The results, which confirm the top line efficacy and safety outcomes reported from the study in February, will be presented tomorrow, September 13, 2014, at the 47th Annual Scientific Meeting of The Retina Society in Philadelphia, PA, by Dr. Hendrik Scholl, the Dr. Frieda Derdeyn Bambas Professor of Ophthalmology and Director of the Visual Neurophysiology Service at the Wilmer Eye Institute at the Johns Hopkins Hospital, and an investigator in the trial. The presentation slides will be made available on QLT's web site following the Retina Society Meeting. Results of the final analysis confirmed the response rates previously reported in February 2014, with 19 of 27 subjects having a visual field response, and 19 of 27 subjects having a visual acuity response.
September 11, 2014
14:03 EDTHCOMHawaiian Telcom subsidiary selected for Hawaiki Cable landing station
Subscribe for More Information
05:28 EDTOCNOcwen Financial resumed with an Equal Weight at Barclays
Target $30.
September 10, 2014
16:03 EDTPIKEPike Electric reports Q4 EPS 13c, consensus 13c
Subscribe for More Information
08:32 EDTESIBofA/Merrill education/prof svcs analyst has analyst/industry conference call
Subscribe for More Information
07:21 EDTQLTIAuxilium sees merger with QLT closing in Q4
Subscribe for More Information
September 9, 2014
10:06 EDTOCNOcwen Financial management to meet with Piper Jaffray
Subscribe for More Information
07:04 EDTOCNOcwen Financial says continues to cooperate fully with NY DFS
Subscribe for More Information
September 4, 2014
20:42 EDTILIAFIliad management to meet with JPMorgan
Meetings to be held in New York on September 8-9 hosted by JPMorgan.
September 2, 2014
14:52 EDTOCNOcwen Financial management to meet with Sterne Agee
Subscribe for More Information
14:51 EDTOCNOcwen Financial management to meet with Piper Jaffray
Subscribe for More Information
08:04 EDTLRELRR Energy to acquire oil and gas producing properties in Oklahoma for $38M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use